Brazilian patients "must compare medicine prices"
This article was originally published in Scrip
Patients in the Brazilian state of Sao Paulo should compare medicine prices across pharmacies before buying, the Procon-SP Research Foundation, which is linked to the secretariat of justice and citizens, has warned.
You may also be interested in...
Health technology assessment body NICE says that Revlimid fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.
The World Trade Organization is not the place to discuss pharmaceutical pricing, and strong intellectual property rights do not threaten access to medicines, according to EU and US delegations to the WTO.
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.